Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan.
Hypertens Res. 2012 Jul;35(7):715-9. doi: 10.1038/hr.2012.17. Epub 2012 Feb 23.
Telmisartan, a selective angiotensin II type 1 receptor blocker, has recently been shown to act as a partial agonist for peroxisome proliferator-activated receptor gamma (PPARγ). To understand how telmisartan partially activates PPARγ, we determined the ternary complex structure of PPARγ, telmisartan, and a coactivator peptide from steroid receptor coactivator-1 at a resolution of 2.18 Å. Crystallographic analysis revealed that telmisartan exhibits an unexpected binding mode in which the central benzimidazole ring is engaged in a non-canonical--and suboptimal--hydrogen-bonding network around helix 12 (H12). This network differs greatly from that observed when full-agonists bind with PPARγ and prompt high-coactivator recruitment through H12 stabilized by multiple hydrogen bonds. Binding with telmisartan results in a less stable H12 that in turn leads to attenuated coactivator binding, thus explaining the mechanism of partial activation.
替米沙坦是一种选择性血管紧张素 II 型 1 型受体阻滞剂,最近已被证明能作为过氧化物酶体增殖物激活受体γ(PPARγ)的部分激动剂。为了了解替米沙坦如何部分激活 PPARγ,我们以 2.18Å 的分辨率确定了 PPARγ、替米沙坦和甾体受体共激活因子-1 的一个共激活肽的三元复合物结构。晶体学分析显示,替米沙坦表现出一种意想不到的结合模式,其中中央苯并咪唑环与 H12 (螺旋 12)周围的非典型(和非最佳)氢键网络结合。该网络与完全激动剂与 PPARγ 结合并通过多个氢键稳定 H12 从而促使高共激活剂募集时观察到的网络有很大不同。与替米沙坦的结合导致 H12 更不稳定,这反过来又导致共激活剂结合减弱,从而解释了部分激活的机制。
Hypertens Res. 2012-2-23
Biomolecules. 2024-8-13
Cancer Chemother Pharmacol. 2024-7
Int J Mol Sci. 2023-1-25
Int J Mol Sci. 2020-12-11
Diabetes Metab Syndr Obes. 2020-10-12
PPAR Res. 2020-7-1